Company Profile
Jinan Xinke Pharmaceutical Science and Technology Co., Ltd. ( XinkePharm ) is an innovative company, which located in the Free-Trade-Zone of Jinan city, Shandong province, China and focus on the researching, manufacturing and marketing of high value-added APIs and their intermediates. Our R&D center covers over 800 square meters, housing a diversity of organic synthesis facilities. We also have a QA laboratory equipped with HPLC, GC, digital melting point apparatus, automatic polarimeter, ultraviolet spectrometer, Karl Fischer Titrator, and pH meters. Our factory cover an area of 6000 square meters and equiped with advanced equipments including 100L-1000L reactors. All the reactors are equipped with nitrogen gas protection system, cooling (-80 degree) and heating system (140 degree). Now our competitive products include Tenofovir alafenamide, Obeticholic acid, Safinamide, Axitinib, Pramipexole,Acotiamide, Donepezil, aclidinium bromide, Ropivacaine, Apixaban, Rivaroxaban and their intermediates. And more promising products in our pipeline under developed. We always hold on our own special field and stick to win the trust of customers with better quality and service. We will work hard to innovate and manufacture quality products, promoting the growth of China pharmaceuticals industry.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
(2S)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanamide |
Propanamide,2-[[[4-[(3-fluorophenyl)methoxy]phenyl]methyl]amino]-,(2S)-;Propanamide,2-[[[4-[(3-fluorophenyl)methoxy]phenyl]methyl]amino]-,(S)-;(2S)-2-[[[4-[(3-Fluorophenyl)methoxy]phenyl]methyl]amino]propanamide;FCE 26743;Safinamide;(S)-2-[[4-[(3-Fluorobenzyl)oxy]benzyl]amino]propanamide;EMD 1195686;(2S)-2-[[4-[(3-Fluorophenyl)methoxy]phenyl]methylamino]propanamide;(S)-2-[[[4-[(3-Fluorophenyl)methoxy]phenyl]methyl]amino]propanamide |
133865-89-1 | Inquiry | |
3-Iodo-6-nitro-1H-indazole |
3-IODO-6-NITROINDAZOLE;3-iodo-6-nitro-2h-indazole;3-IODO-6-NITRO (1H)INDAZOLE;1H-Indazole, 3-iodo-6-nitro-;3-Iodo-6-nitro-1H-indazole ,97% |
70315-70-7 | Inquiry | |
4-Thiazolecarboxylic acid, 2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-, methyl ester |
4-Thiazolecarboxylic acid,2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-,methyl ester;Methyl 2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-4-thiazolecarboxylate;2-[(2-Hydroxy-4,5-dimethoxybenzoyl)amino]-1,3-thiazole-4-carboxylic acid methyl ester |
877997-99-4 | Inquiry | |
6-ECDCA |
Cholan-24-oic acid,6-ethyl-3,7-dihydroxy-,(3α,5β,6α,7α)-;(3α,5β,6α,7α)-6-Ethyl-3,7-dihydroxycholan-24-oic acid;6-Ethylchenodeoxycholic acid;3α,7β-Dihydroxy-6α-ethyl-5β-cholan-24-oic acid;Obeticholic acid;INT 747;6α-Ethylchenodeoxycholic acid;6-ECDCA;Ocaliva |
459789-99-2 | Inquiry | |
6-nitro-3-[(E)-2-(2-pyridyl)vinyl]-1-tetrahydropyran-2-yl-indazole |
1H-Indazole,6-nitro-3-[(1E)-2-(2-pyridinyl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-;6-Nitro-3-[(1E)-2-(2-pyridinyl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole;(E)-6-Nitro-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole |
886230-75-7 | Inquiry | |
Axitinib |
Benzamide,N-methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]-;N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]benzamide;AG 013736;Axitinib;Inlyta;790713-39-2 |
319460-85-0 | Inquiry | |
Donepezil hydrochloride |
1H-Inden-1-one,2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-,hydrochloride (1:1);1H-Inden-1-one,2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-,hydrochloride;E 2020;E 2020 (pharmaceutical);BNAG;Donepezil hydrochloride;Aricept;Aricept D;Dopezil;Dorent;Donep;1-Benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine hydrochloride;Aricept ODT;142057-77-0 |
120011-70-3 | Inquiry | |
PHENYL 2-HYDROXY-4,5-DIMETHOXYBENZOATE |
877997-98-3 | Inquiry | ||
Phenyl hydrogen [(R)-1-(6-amino-9H-purin-9-yl)propan-2-yloxy]methylphosphonate |
[[(1R)-2-(6-aMino-9H-purin-9-yl)-1-Methylethoxy]Methyl]-, Monophenylester;Tenofovir Related Compound 2;phenyl ((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphonate;GS7340 impurity1;GS7340 intermediate 1;phenylydrogen((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)
phosphonate;phenyl hydrogen (R)-((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphonate;Phenyl hydrogen ({[(2R)-1-(6-amino-9H-purin-9-yl)-2-propanyl]oxy}methyl)phosphonate |
379270-35-6 | Inquiry | |
Safinamide mesylate salt |
Propanamide,2-[[[4-[(3-fluorophenyl)methoxy]phenyl]methyl]amino]-,(2S)-,methanesulfonate (1:1);Propanamide,2-[[[4-[(3-fluorophenyl)methoxy]phenyl]methyl]amino]-,(S)-,monomethanesulfonate;Propanamide,2-[[[4-[(3-fluorophenyl)methoxy]phenyl]methyl]amino]-,(2S)-,monomethanesulfonate;PNU 151774E;NW 1015;Safinamide mesylate;(S)-2-[[4-[(3-Fluorobenzyl)oxy]benzyl]amino]propanamide methanesulfonate;Safinamide methanesulfonate;EMD 1195686 mesylate;Xadago |
202825-46-5 | Inquiry | |
Tenofovir alafenamide hemifumarate |
L-Alanine,N-[(S)-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-, 1-methylethyl ester, (2E)-2-butenedioate (2:1);N-[(S)-[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-L-alanine 1-methylethyl ester (2E)-2-butenedioate (2:1);GS-7340 (hemifumarate);TENOFOVIR ALAFENAMIDE HEMIFUMARATE (GS-7340 HEMIFUMARATE);Tenofovir levamide amine fumarate;GS7340(Tenofovir Alafenamide Fumarate);(Tenofovir alafenamide : fumarate = 2:1);Anti-HIV |
1392275-56-7 | Inquiry | |
Tenofovir alanamide |
L-Alanine,N-[(S)-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-,1-methylethyl ester;GS 7340;Tenofovir alafenamide;4: PN: WO2016077321 SEQID: 4 claimed sequence;Vemlidy;377091-31-1 |
379270-37-8 | Inquiry |